Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I, single ascending dose trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of VTP 43742 in healthy volunteers

Next Previous
Trial Profile

A phase I, single ascending dose trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of VTP 43742 in healthy volunteers

Status: Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Jul 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Vimirogant (Primary)
  • Indications Autoimmune disorders; Multiple sclerosis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Vitae Pharmaceuticals

Most Recent Events

  • 17 May 2016 Results of this and other study (see profile 255432) presented at the IMMUNOLOGY 2016™ American Association of Immunologists Annual Meeting
  • 09 May 2016 Data will be presented at the IMMUNOLOGY 2016, the American Association of Immunologists' annual meeting according to a Vitae Pharmaceuticals media release.
  • 08 Sep 2015 Top-line results were published in a Vitae Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top